December 20th, 2021 · Common Contracts · 1000 similar Battery Future Acquisition Corp. – INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of December 14, 2021 by and between Battery Future Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
This Investment Management Trust Agreement (this “Agreement”) is made effective as of December 14, 2021 by and between Battery Future Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
March 25th, 2022 · Common Contracts · 1000 similar Histogen Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 22, 2022, between Histogen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of March 22, 2022, between Histogen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
November 8th, 2021 · Common Contracts · 1000 similar Spindletop Health Acquisition Corp. – INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of November 3, 2021, by and between Spindletop Health Acquisition Corp., a Delaware corporation (the “Company”), and Evan S. Melrose (“Indemnitee”).
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of November 3, 2021, by and between Spindletop Health Acquisition Corp., a Delaware corporation (the “Company”), and Evan S. Melrose (“Indemnitee”).
June 13th, 2005 · Common Contracts · 1000 similar Saflink Corp – REGISTRATION RIGHTS AGREEMENT This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof among the Company and the Purchasers (the “Purchase Agreement”).
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof among the Company and the Purchasers (the “Purchase Agreement”).
January 14th, 2022 · Common Contracts · 1000 similar First Digital Health Acquisition Corp. – WARRANT AGREEMENT FIRST DIGITAL HEALTH ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this “Agreement”), dated as of [●], 2022, is by and between First Digital Health Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity, the “Warrant Agent”).
THIS WARRANT AGREEMENT (this “Agreement”), dated as of [●], 2022, is by and between First Digital Health Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity, the “Warrant Agent”).
January 14th, 2022 · Common Contracts · 1000 similar First Digital Health Acquisition Corp. – Underwriting Agreement First Digital Health Acquisition Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (collectively, the “Underwriters”), for whom you are acting as representative (in such capacity, the “Representative”), an aggregate of 17,500,000 units (the “Units”) of the Company (the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 2,625,000 additional Units to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). In the event that only one Underwriter is listed in Schedule A hereto, any references to the “Underwriters” shall be deemed to refer to the sole Underwriter in the singular form listed in such Schedule A to this underwriting agreement (this “Agreement”).
First Digital Health Acquisition Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (collectively, the “Underwriters”), for whom you are acting as representative (in such capacity, the “Representative”), an aggregate of 17,500,000 units (the “Units”) of the Company (the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 2,625,000 additional Units to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). In the event that only one Underwriter is listed in Schedule A hereto, any references to the “Underwriters” shall be deemed to refer to the sole Underwriter in the singular form listed in such Schedule A to this underwriting agreement (this “Agreement”).
May 24th, 2022 · Common Contracts · 1000 similar Halozyme Therapeutics, Inc. – CREDIT AGREEMENT Dated as of May 24, 2022 among HALOZYME THERAPEUTICS, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, a Swing Line Lender and an L/C Issuer, and The Other Lenders and L/C Issuers Party Hereto BofA SECURITIES,... This CREDIT AGREEMENT (“Agreement”) is entered into as of May 24, 2022, among HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), HALOZYME, INC., a California corporation, each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), each L/C Issuer (as hereinafter defined) from time to time party hereto and BANK OF AMERICA, N.A., as Administrative Agent and Swing Line Lender.
This CREDIT AGREEMENT (“Agreement”) is entered into as of May 24, 2022, among HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), HALOZYME, INC., a California corporation, each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), each L/C Issuer (as hereinafter defined) from time to time party hereto and BANK OF AMERICA, N.A., as Administrative Agent and Swing Line Lender.
December 20th, 2021 · Common Contracts · 1000 similar Battery Future Acquisition Corp. – WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of December 14, 2021, is by and between Battery Future Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”, and also referred to herein as the “Transfer Agent”).
THIS WARRANT AGREEMENT (this “Agreement”), dated as of December 14, 2021, is by and between Battery Future Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”, and also referred to herein as the “Transfer Agent”).
May 2nd, 2014 · Common Contracts · 990 similar Aceto Corp – CREDIT AGREEMENT dated as of April 30, 2014 among ACETO CORPORATION The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent and WELLS FARGO BANK, NATIONAL ASSOCIATION as Syndication Agent Schedule 2.01 – Commitments Schedule 2.06 – Existing Letters of Credit Schedule 3.05 – Intellectual Property Schedule 3.06 – Litigation Schedule 3.11 – Subsidiaries Schedule 3.12 – Hazardous Materials Schedule 3.17 – Material Contracts Schedule 3.20 – Insurance Schedule 6.01 – Existing Liens Schedule 6.02 – Existing Indebtedness Schedule 6.03 – Existing Guarantees Schedule 6.18 – Existing Restrictive Agreements
Schedule 2.01 – Commitments Schedule 2.06 – Existing Letters of Credit Schedule 3.05 – Intellectual Property Schedule 3.06 – Litigation Schedule 3.11 – Subsidiaries Schedule 3.12 – Hazardous Materials Schedule 3.17 – Material Contracts Schedule 3.20 – Insurance Schedule 6.01 – Existing Liens Schedule 6.02 – Existing Indebtedness Schedule 6.03 – Existing Guarantees Schedule 6.18 – Existing Restrictive Agreements
April 4th, 2019 · Common Contracts · 914 similar STAG Industrial, Inc. – STAG INDUSTRIAL, INC. (a Maryland corporation) 6,500,000 Shares of Common Stock UNDERWRITING AGREEMENT
December 20th, 2021 · Common Contracts · 876 similar Battery Future Acquisition Corp. – UNDERWRITING AGREEMENT between BATTERY FUTURE ACQUISITION CORP. and CANTOR FITZGERALD & CO. As Representative of the Underwriters Dated: December 14, 2021 The undersigned, Battery Future Acquisition Corp., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with Cantor Fitzgerald & Co. (“Cantor” or the “Representative”) and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the “Underwriters” or, each underwriter individually, an “Underwriter”) as follows:
The undersigned, Battery Future Acquisition Corp., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with Cantor Fitzgerald & Co. (“Cantor” or the “Representative”) and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the “Underwriters” or, each underwriter individually, an “Underwriter”) as follows:
May 22nd, 2007 · Common Contracts · 846 similar Inter-Atlantic Financial, Inc. – Exhibit 10.5 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT") is entered into as of the __ day of _________, 2007, by and among Inter-Atlantic Financial, Inc. (the "COMPANY") and the undersigned parties listed under...
January 17th, 2020 · Common Contracts · 791 similar PDS Biotechnology Corp – UNDERWRITING AGREEMENT between PDS BIOTECHNOLOGY CORPORATION and as Representative of the Several Underwriters The undersigned, PDS Biotechnology Corporation, a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of PDS Biotechnology Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
The undersigned, PDS Biotechnology Corporation, a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of PDS Biotechnology Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
July 28th, 2020 · Common Contracts · 686 similar BigCommerce Holdings, Inc. – INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [Date] by and between BigCommerce Holdings, Inc., a Delaware corporation (the “Company”) and (“Indemnitee”). Capitalized terms used herein without definition shall have the meanings assigned to such terms in Section 13.
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [Date] by and between BigCommerce Holdings, Inc., a Delaware corporation (the “Company”) and (“Indemnitee”). Capitalized terms used herein without definition shall have the meanings assigned to such terms in Section 13.
April 18th, 2022 · Common Contracts · 627 similar Liquidia Corp – 9,803,922 Shares Liquidia Corporation UNDERWRITING AGREEMENT Introductory. Liquidia Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 9,803,922 shares of its common stock, par value $0.001 per share (the “Shares”). The 9,803,922 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,470,588 Shares as provided in Section 2. The additional 1,470,588 Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” BofA Securities, Inc. (“BofA”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriter
Introductory. Liquidia Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 9,803,922 shares of its common stock, par value $0.001 per share (the “Shares”). The 9,803,922 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,470,588 Shares as provided in Section 2. The additional 1,470,588 Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” BofA Securities, Inc. (“BofA”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriter
December 20th, 2021 · Common Contracts · 617 similar Virtuoso Acquisition Corp. 2 – INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [ ], 2021, by and between Virtuoso Acquisition Corp. 2, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
This Investment Management Trust Agreement (this “Agreement”) is made effective as of [ ], 2021, by and between Virtuoso Acquisition Corp. 2, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
April 20th, 2021 · Common Contracts · 599 similar Columbus McKinnon Corp – Columbus McKinnon Corporation [●] Shares of Common Stock Form of Underwriting Agreement On April 7, 2021, the Company consummated an acquisition of Dorner (as defined below) pursuant to an Agreement and Plan of Merger, dated as of March 1, 2021 (as amended and supplemented and as the same may be amended and supplemented after the date hereof, the “Merger Agreement,” which term, as used herein, includes all exhibits, schedules and attachments thereto, in each case as amended or supplemented, if applicable), by and among Dorner Merger Sub Inc. (“Merger Sub”), Precision Blocker, Inc. (“Precision”) and Precision TopCo LP, pursuant to which Merger Sub merged with and into Precision with Precision continuing as the surviving corporation and a wholly owned subsidiary of the Company, along with its indirect wholly-owned subsidiary Dorner Mfg. Corp. (“Dorner”).
On April 7, 2021, the Company consummated an acquisition of Dorner (as defined below) pursuant to an Agreement and Plan of Merger, dated as of March 1, 2021 (as amended and supplemented and as the same may be amended and supplemented after the date hereof, the “Merger Agreement,” which term, as used herein, includes all exhibits, schedules and attachments thereto, in each case as amended or supplemented, if applicable), by and among Dorner Merger Sub Inc. (“Merger Sub”), Precision Blocker, Inc. (“Precision”) and Precision TopCo LP, pursuant to which Merger Sub merged with and into Precision with Precision continuing as the surviving corporation and a wholly owned subsidiary of the Company, along with its indirect wholly-owned subsidiary Dorner Mfg. Corp. (“Dorner”).
March 10th, 2016 · Common Contracts · 532 similar International Stem Cell CORP – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 9, 2016, between International Stem Cell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of March 9, 2016, between International Stem Cell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
December 5th, 2017 · Common Contracts · 523 similar Everi Holdings Inc. – EVERI PAYMENTS INC. 7.50% SENIOR UNSECURED NOTES DUE 2025 INDENTURE Dated as of December 5, 2017 Deutsche Bank Trust Company Americas, as Trustee INDENTURE dated as of December 5, 2017 by and among Everi Payments Inc., a Delaware corporation (including any and all successors thereto, the “Company”), and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”).
INDENTURE dated as of December 5, 2017 by and among Everi Payments Inc., a Delaware corporation (including any and all successors thereto, the “Company”), and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”).
May 28th, 2021 · Common Contracts · 467 similar Bowl America Inc – AGREEMENT AND PLAN OF MERGER among BOWLERO CORP., POTOMAC MERGER SUB, INC. and BOWL AMERICA INCORPORATED dated as of May 27, 2021 THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of May 27, 2021 by and among Bowlero Corp., a Delaware corporation (“Parent”), Potomac Merger Sub, Inc., a Maryland corporation and wholly owned subsidiary of Parent (“Merger Sub”), and Bowl America Incorporated, a Maryland corporation (the “Company”). Capitalized terms used but not defined in the context in which they are used shall have the respective meanings assigned to such terms in Section 9.15.
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of May 27, 2021 by and among Bowlero Corp., a Delaware corporation (“Parent”), Potomac Merger Sub, Inc., a Maryland corporation and wholly owned subsidiary of Parent (“Merger Sub”), and Bowl America Incorporated, a Maryland corporation (the “Company”). Capitalized terms used but not defined in the context in which they are used shall have the respective meanings assigned to such terms in Section 9.15.
January 25th, 2021 · Common Contracts · 426 similar On24 Inc – ON24, Inc. Common Stock, par value $0.0001 per share Underwriting Agreement ON24, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [●] shares and, at the election of the Underwriters, up to [●] additional shares of Common Stock, par value $0.0001 per share (“Stock”) of the Company, and the stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”) propose, subject to the terms and conditions stated in this Agreement, to sell to the Underwriters an aggregate of [●] shares of Stock. The aggregate of [●] shares to be sold by the Company and the Selling Stockholders is herein called the “Firm Shares” and the aggregate of [●] additional shares to be sold by the Company is herein called the “Optional Shares”. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Sh
ON24, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [●] shares and, at the election of the Underwriters, up to [●] additional shares of Common Stock, par value $0.0001 per share (“Stock”) of the Company, and the stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”) propose, subject to the terms and conditions stated in this Agreement, to sell to the Underwriters an aggregate of [●] shares of Stock. The aggregate of [●] shares to be sold by the Company and the Selling Stockholders is herein called the “Firm Shares” and the aggregate of [●] additional shares to be sold by the Company is herein called the “Optional Shares”. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Sh
March 10th, 2021 · Common Contracts · 419 similar Rimini Street, Inc. – 7,750,000 Shares RIMINI STREET, INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT March 9, 2021 Rimini Street, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), for whom Craig-Hallum Capital Group LLC (the “Representative”) is acting as Representative , an aggregate of 7,750,000 shares of common stock, par value $0.0001 per share, of the Company (the “Firm Shares”). The Company and certain stockholders of the Company (the “Selling Stockholders”) named in Schedule I hereto. are hereinafter sometimes collectively referred to as the “Sellers.”
Rimini Street, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), for whom Craig-Hallum Capital Group LLC (the “Representative”) is acting as Representative , an aggregate of 7,750,000 shares of common stock, par value $0.0001 per share, of the Company (the “Firm Shares”). The Company and certain stockholders of the Company (the “Selling Stockholders”) named in Schedule I hereto. are hereinafter sometimes collectively referred to as the “Sellers.”
March 29th, 2021 · Common Contracts · 400 similar VERRA MOBILITY Corp – VM CONSOLIDATED, INC., the Guarantors from time to time party hereto and WILMINGTON TRUST, NATIONAL ASSOCIATION as Trustee $350,000,000 5.50% SENIOR NOTES DUE 2029 INDENTURE Dated as of March 26, 2021 INDENTURE dated as of March 26, 2021 among VM Consolidated, Inc., a Delaware corporation (the “Issuer”), the Guarantors (as defined herein) from time to time party hereto and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”).
INDENTURE dated as of March 26, 2021 among VM Consolidated, Inc., a Delaware corporation (the “Issuer”), the Guarantors (as defined herein) from time to time party hereto and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”).
June 15th, 2021 · Common Contracts · 399 similar UpHealth, Inc. – UPHEALTH, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 9, 2021 6.25% Convertible Senior Notes due 2026 INDENTURE dated as of June 9, 2021 between UPHEALTH, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
INDENTURE dated as of June 9, 2021 between UPHEALTH, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
October 27th, 2021 · Common Contracts · 385 similar Capitalworks Emerging Markets Acquisition Corp – FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [__________ ___] , 2021, by and between Capitalworks Emerging Markets Acquisition Corp, a Cayman Islands exempted company (the “Company”), and [_____] (“Indemnitee”).
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [__________ ___] , 2021, by and between Capitalworks Emerging Markets Acquisition Corp, a Cayman Islands exempted company (the “Company”), and [_____] (“Indemnitee”).
August 14th, 2012 · Common Contracts · 374 similar Westinghouse Solar, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 14, 2012, between Westinghouse Solar, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of August 14, 2012, between Westinghouse Solar, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
December 13th, 2010 · Common Contracts · 374 similar International Stem Cell CORP – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 9, 2010, by and between INTERNATIONAL STEM CELL CORPORATION, a Delaware corporation, (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 9, 2010, by and between INTERNATIONAL STEM CELL CORPORATION, a Delaware corporation, (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
December 29th, 2020 · Common Contracts · 370 similar Histogen Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December , 2020, between Histogen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of December , 2020, between Histogen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
December 29th, 2006 · Common Contracts · 362 similar HD Partners Acquisition CORP – WARRANT AGREEMENT Agreement made as of June 7, 2006 between HD Partners Acquisition Corporation, a Delaware corporation, with offices at 2601 Ocean Park Boulevard, Suite 320, Santa Monica, California 90405 (“Company”), and American Stock Transfer & Trust Company, a New York corporation, with offices at 59 Maiden Lane, Plaza Level, New York, New York 10038 (“Warrant Agent”).
Agreement made as of June 7, 2006 between HD Partners Acquisition Corporation, a Delaware corporation, with offices at 2601 Ocean Park Boulevard, Suite 320, Santa Monica, California 90405 (“Company”), and American Stock Transfer & Trust Company, a New York corporation, with offices at 59 Maiden Lane, Plaza Level, New York, New York 10038 (“Warrant Agent”).
February 22nd, 2022 · Common Contracts · 341 similar Color Star Technology Co., Ltd. – SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 21, 2022, is by and among Color Star Technology Co., Ltd., a Cayman Islands company with headquarters located at 7 World Trade Center, Suite 4621, New York, NY 10007 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 21, 2022, is by and among Color Star Technology Co., Ltd., a Cayman Islands company with headquarters located at 7 World Trade Center, Suite 4621, New York, NY 10007 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
July 29th, 2019 · Common Contracts · 338 similar Axsome Therapeutics, Inc. – Contract THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
June 29th, 2021 · Common Contracts · 337 similar Elicio Therapeutics, Inc. – Elicio Therapeutics, Inc. Common Stock Underwriting Agreement Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as the representatives (the “Representatives”), an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of common stock, par value $0.01 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
Elicio Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as the representatives (the “Representatives”), an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of common stock, par value $0.01 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
April 2nd, 2021 · Common Contracts · 317 similar Bsquare Corp /Wa – BSQUARE CORPORATION Common Stock (no par value) At Market Issuance Sales Agreement
March 11th, 2013 · Common Contracts · 313 similar CAREFUSION Corp – REGISTRATION RIGHTS AGREEMENT by and among CareFusion Corporation and Merrill Lynch, Pierce, Fenner & Smith Incorporated Morgan Stanley & Co. LLC Dated as of March 11, 2013 This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 11, 2013, by and among CareFusion Corporation, a Delaware corporation (the “Company”), and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and other initial purchasers (collectively, the “Initial Purchasers”), each of whom has agreed to purchase the Company’s 3.300% Senior Notes due 2023 (the “Initial Securities”) pursuant to the Purchase Agreement (as defined below).
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 11, 2013, by and among CareFusion Corporation, a Delaware corporation (the “Company”), and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC and other initial purchasers (collectively, the “Initial Purchasers”), each of whom has agreed to purchase the Company’s 3.300% Senior Notes due 2023 (the “Initial Securities”) pursuant to the Purchase Agreement (as defined below).
April 12th, 2021 · Common Contracts · 300 similar Akoya Biosciences, Inc. – Akoya Biosciences, Inc. [--] Shares of Common Stock Underwriting Agreement Akoya Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [--] shares of common stock, par value $0.00001 per share, of the Company (the “Underwritten Shares” and, at the option of the Underwriters, up to an additional [--] shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Akoya Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [--] shares of common stock, par value $0.00001 per share, of the Company (the “Underwritten Shares” and, at the option of the Underwriters, up to an additional [--] shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.